Sales OrdersMy gut tells me that since KNR first publicly announced BioCloud and the ability to detect airborne Covid-19 virus that they have been inundated with potential orders. It would not surprise me the have a huge backlog but they could not act on the sales or refused to until they had all their ducks in line like CSA/UL approval, manufacturing in place, distribution channels, field testing and patents in place.
The CEO is very conservative in my opinion and risk adversed and very thorough, methodical and calculated.
I believe we are very close to announcing numerous sales/purchase orders and in my opinion the demand will outstrip the supply. Covid-19 cases continue to rise globally setting new daily records, experts project cases will continue to rise. Many countries, cities going back into lock down and cannot handle more negative economic impact. Cracks are starting appear with some of the vaccines they are rushing to market.
Manufaturing 20,000 units per month is a spit in the bucket compared to what the global demand will be once this product makes mainstream news.
I personally look forward to December and 2021!